About Carolus Pharmaceuticals Private Limited
Data last updated:
Carolus Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 16 May 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2018PTC333987.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Sheikh Wasiullah Kalim and Mohd Shamsad Ahmad.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at T – 230/1 F.F. Baljeet Nagar West Patel Nagar, New Delhi, Delhi, India – 110008.
As per the financials filed for FY 2024, the company reported a revenue of ₹5.82 Lakh, a decline of 63% compared to the previous year. For the same year it recorded a net loss of ₹14,242 (net margin -2.4%) and EBITDA of -₹14,242 (EBITDA margin -2.4%). Revenue has grown at a compounded annual rate (CAGR) of 82% over five years.
For more details, the company can be reached via its website caroluspharma.com.
Company details
Contact details
Carolus Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its website is caroluspharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressT – 230/1 F.F. Baljeet Nagar West Patel Nagar, New Delhi, Delhi, India – 110008
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Carolus Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Carolus Pharmaceuticals Private Limited
FY 2025 filings availableCarolus Pharmaceuticals Private Limited reported revenue of ₹5.82 Lakh (down 63% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 63% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 82%. EBITDA rose 97% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹14,242 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹14,242 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -2.4% | ||||
| Net Profit Margin | -2.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Carolus Pharmaceuticals Private Limited, buy the company report.
Board of directors of Carolus Pharmaceuticals Private Limited
Carolus Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sheikh Wasiullah Kalim | Director | 19 Nov 2021 | 4 Years 11 Months | Current |
| Mohd Shamsad Ahmad | Director | 16 May 2018 | 8 Years 5 Months | Current |
| Amanullah Kaleem | Director | 16 May 2018 | 8 Years 5 Months | Current |
Peer comparison
Carolus Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pimex India Private Limited | ₹5.82 Lakh (FY 2025) | 35.0% | Mumbai, Maharashtra, India | |||
| Ceflact Pharmaceuticals Private Limited | ₹5.82 Lakh (FY 2024) | 19.0% | Allahabad, Uttar Pradesh, India | |||
| Carolus Pharmaceuticals Private Limitedthis company | ₹5.82 Lakh (FY 2024) | -₹14,242 | -2.4% | -63.0% | New Delhi, Delhi, India | |
| Mansfield Laboratories Private Limited | ₹5.77 Lakh (FY 2017) | -3.0% | Uttar Pradesh, India |
To see the full peer comparison of Carolus Pharmaceuticals Private Limited, buy the company report.
Auditor
Carolus Pharmaceuticals Private Limited is audited by B K C AND ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B K C AND ASSOCIATES | FY 2021 | 027531N |
Shareholding
The shareholding of Carolus Pharmaceuticals Private Limited is on record for FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Carolus Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Carolus Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Carolus Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Carolus Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Carolus Pharmaceuticals Private Limited has 4 board changes on record since 2018: 3 appointments and 1 cessation. The latest: Sheikh Wasiullah Kalim was appointed as Director on 19 Nov 2021.
Frequently asked questions
Carolus Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 16 May 2018 (8+ years old) and is registered under CIN U74999DL2018PTC333987.
Carolus Pharmaceuticals has 3 current directors:
- Sheikh Wasiullah Kalim - Director
- Mohd Shamsad Ahmad - Director
- Amanullah Kaleem - Director
The latest financial statements of Carolus Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The CIN (Corporate Identification Number) of Carolus Pharmaceuticals is U74999DL2018PTC333987. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Carolus Pharmaceuticals was incorporated on 16 May 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Carolus Pharmaceuticals by revenue are Pimex India Private Limited, Ceflact Pharmaceuticals Private Limited, Mansfield Laboratories Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Sheikh Wasiullah Kalim was appointed as Director on 19 Nov 2021. Aaftab Ahmad Ansari ceased to be Director on 25 Jun 2021. Amanullah Kaleem was appointed as Director on 16 May 2018. Carolus Pharmaceuticals has 4 board changes on record in total.
Carolus Pharmaceuticals can be reached through the website caroluspharma.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Carolus Pharmaceuticals is at T – 2301 F.F. Baljeet Nagar West Patel Nagar, New Delhi, Delhi, India – 110008.
Carolus Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Carolus Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
